Home / Stock ratings / HUM
Stock rating · Hospital & Medical Service Plans
Humana Inc. (HUM) Stock Rating & Analysis
As of October 9, 2026, MELANY rates Humana Inc. 64 out of 100 (Catalyst Watch). Its highest factor score is price momentum at 82, and its lowest is business quality at 31.
MELANY ratingRated 2026-10-09HUM · composite score
About Humana Inc.
Humana is among the largest private health insurers in the US and specializes in government-sponsored programs, with nearly all of its medical membership coming from Medicare, Medicaid, and the military's Tricare program. Beyond medical insurance, it offers other healthcare services including primary care, at-home services, and pharmacy benefit management.
Rating as of 2026-10-09 · this is a dated snapshot; the live rating is in the app (Pro, free for 30 days). The price above updates in real time.
Why HUM scores 64/100
HUM's 8 factor scores run from 31 to 82, and 4 of them sit above its composite of 64. Here is how HUM breaks down.
Whether the price looks cheap or expensive against earnings, growth, and peers.
- Forward P/E 25.8x, earnings growth accelerating
Margins, returns on capital, and balance-sheet strength.
Direction and relative strength of the recent share-price trend.
- Price +12.7% above 50-day MA
- 50-day MA above 200-day (golden cross zone)
History of beating or missing estimates, and where estimates are heading.
- Beat EPS estimates 4 of last 4 quarters
- Avg EPS beat +5%
- Earnings in 28 days (strong beat history)
What Wall Street price targets and revisions are signalling.
Near-term events that could move the stock.
- Earnings in 28 days
Upside weighed against volatility and drawdown risk.
How the current rate and market regime suits this kind of company.
How HUM compares
As of October 13, 2026, Humana Inc. ranks 3rd of the 4 companies with a MELANY rating page in its SEC industry group (Hospital & Medical Service Plans), where the average score is 67.
Key risks for HUM
- Trading near 52-week high, limited upside without new positive catalyst
Sector and theme context
Humana Inc. sits in the Healthcare sector theme, which MELANY currently rates 53/100 for strength. Theme strength feeds HUM's momentum and catalyst factors above.
HUM trade plan (Pro)
MELANY has a full position plan for Humana Inc.: a smart entry zone, an alert level, position sizing, and quarterly review triggers. It is part of Market Eyes Pro, and the first 30 days are free.
How MELANY rates HUM
MELANY is a rules-based engine that scores every stock from 0 to 100 across eight weighted factors, then re-scores as new price, earnings, and fundamental data arrive. Humana Inc.'s 64/100 reflects mature factor weighting for its profile. Single-event catalyst trade: small size, short fuse, tight stop..
Ratings are algorithmic and change with the data. They are research and education, not personalized investment advice.
Frequently asked questions about HUM
Is Humana Inc. (HUM) a buy?
As of 2026-10-09, MELANY rated Humana Inc. Catalyst Watch with a composite score of 64/100. That is a dated snapshot, not the live rating, and it is an algorithmic reading built from eight factors rather than personalized investment advice. Review the factor breakdown above and the disclaimer below before making any decision.
What is Humana Inc.'s MELANY score?
Humana Inc. (HUM) has a MELANY composite score of 64/100, combining valuation, business quality, price momentum, earnings track record, analyst sentiment, catalyst setup, risk-adjusted profile, macro fit.
How is the HUM stock rating calculated?
MELANY scores HUM from 0 to 100 across eight weighted factors using live market and fundamental data, then refreshes the rating automatically as new data arrives.
Should I buy Humana Inc. stock?
That decision is yours; Market Eyes Live does not give buy or sell advice. What the data says: MELANY rates Humana Inc. (HUM) Catalyst Watch with a composite of 64/100 as of 2026-10-09. The factor breakdown above shows what is driving that, which is a better basis for a decision than any one-word verdict.
What is the HUM stock price forecast?
MELANY does not publish price targets or forecasts for HUM. Predicting a future price is exactly the kind of false precision the confidence framework avoids. Instead it scores today's setup, 64/100 across eight factors for Humana Inc., and re-scores automatically as new price, earnings, and fundamental data arrive.
Is HUM stock overvalued or undervalued?
MELANY's valuation factor currently reads 54/100 for Humana Inc., where a higher score means the price looks more attractive on that measure. Scores in the 70s and above read as attractively priced, the mid range as roughly fair, and low scores as stretched. The factor breakdown above shows what drives HUM's read.
What price should I buy HUM at?
Rather than chasing the current price, MELANY computes a smart entry zone for HUM: the price area where risk and reward actually favor a new position, plus an alert level and position sizing. The exact levels are part of Market Eyes Pro, which starts with a 30-day free trial.
What are the risks of buying HUM stock?
The top risks MELANY currently flags for Humana Inc.: Trading near 52-week high, limited upside without new positive catalyst. The rating on this page already weighs these against the bullish factors; see the risk-adjusted profile score in the breakdown above.
Is Humana Inc. a good long-term investment?
For long-term durability the two factors that matter most are business quality, which MELANY scores 31/100 for Humana Inc., and earnings track record, at 78/100. The 64/100 composite blends those with six shorter-horizon factors. Durable quality at a fair price is the long-term case to test; this is research, not personalized investment advice.
Will HUM stock go up?
Nobody can promise a stock's direction, and Market Eyes Live does not predict prices. The measurable part: MELANY's price momentum factor reads 82/100 for HUM right now, and the catalyst setup factor tracks whether near-term events could move it. Both re-score automatically as the data changes.
How current is this HUM rating?
The rating on this page is a snapshot of MELANY's read as of 2026-10-09. The price shown updates live, but the score is not recomputed on this page. MELANY re-scores HUM continuously as new price, earnings, and fundamental data arrive, and the current rating is in the app (Pro, free for 30 days).
How this rating works
Market Eyes Live
Every rating graded in public, HUM included
MELANY scores more than 11,000 U.S. stocks and ETFs, PRISM ranks conviction and APEX writes the plan with one entry zone. Free to start on iOS and the web.